Comparative study between high flow nasal cannula, high velocity nasal insufllation and noninvasive ventilation in management of acute respiratory failure
Keywords:
high-flow nasal cannula, high velocity nasal insufflation, non invasive ventilation, acute respiratory failureAbstract
Background: Evidene supporting the benefits of High velocity nasal insufflation (HVNI)and High flow nasal cannula (HFNC) in mangment of Acute respiratory failure in adults beside Non invasive ventilation (NIV) has been proved. The work aim was to evaluate the advantages, efficacy and the hazards of HVNI/HFNC in comparison to those of NIV with acute hypoxemic and hypercapnic respiratory failure. Patients and methods: A prospective analytical study of 60 patients with ARF were randomized to receive either non-invasive positive pressure ventilation (NIV) using an oronasal mask 30/60(50%), high-velocity nasal insufflation (HVNI) 17/60(28.3%), or High-flow nasal cannula (HFNC) 13/60(21.7%). Precision Flow® Hi-VNI Packaging(Vapotherm Inc., USA) as HVNI device which delivered air flows between 35 and 60 L/min. Temperature was set at 34°C or 37°C, whereas FiO2 was controlled to gain arterial oxygen saturation (SpO2) above 92%(that made PEEP from 1.7 to 5).
Downloads
References
Koga Y, Kaneda K, Fujii N, Tanaka R, Miyauchi T, Fujita M, et al. Comparison of high-flow nasal cannula oxygen therapy and non-invasive ventilation as first-line therapy in respiratory failure: a multicenter retrospective study. Acute Med Surg. 2020;7:461-8.
Grieco DL, Menga LS, Raggi V, Bongiovanni F, Anzellotti GM, Tanzarella ES, et al. Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2020;201:303-12.
Frat J-P, Coudroy R, Marjanovic N, Thille AW. High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. Ann TranslMed. 2017;5:50-9.
Nishimura M. High-flow nasal cannula oxygen therapy in adults: Physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61:529-41.
Spicuzza L, Schisano M. High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future. Ther Adv Chronic Dis. 2020;11:20-41.
Oczkowski S, Ergan B, Bos L, Chatwin M, Ferrer M. ERS clinical practice guidelines: high -flow nasal cannula in acute respiratory failure. EUROPEAN RESPIRATORY journal.2021 DOI: 10.1183/13993003.01574-2021.
Cabrini L, Landoni G, Zangrillo A. Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure. Lancet. 2020;395:685-99.
Vapotherm-Precision-Flow-Plus-Quick-Reference-Guide.pdf. 2020
Frat J-P, Coudroy R, Marjanovic N, Thille AW. High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. Ann TranslMed. 2017;5:50-9.
da Silva Costa WN, Miguel JP, dos Santos Prado F, de Mello Lula LHS, Amarante GAJ, Righetti RF, et al. Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes. RESPNB. 2022;298:103842.
Agmy G, Adam M, Hsanen EH, Mahmoud MA. High-flow nasal cannula versus noninvasive ventilation in the prevention of escalation to invasive mechanical ventilation in patients with acute hypoxemic respiratory failure. DOAJ. 2022;71:81-9.
Elagamy AE, Taha SS, Elfawy DM. High flow nasal cannula versus non-invasive ventilation in prevention of intubation in immunocompromised patient with acute hypoxemic respiratory failure. Egypt J Anaesth. 2021;37:432-9.
Hao J, Liu J, Pu L, Li C, Zhang M, Tan J, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation in aids patients with acute respiratory failure: a randomized controlled trial. J Clin Med. 2023;12:1-11.
Ovtcharenko N, Ho E, Alhazzani W, Cortegiani A, Ergan B, Scala R, et al. High-flow nasal cannula versus non-invasive ventilation for acute hypercapnic respiratory failure in adults: a systematic review and meta-analysis of randomized trials. Crit Care. 2022;26:1-14.
Plotnikow GA, Accoce M, Fredes S, Tiribelli N, Setten M, Dorado J, et al. High-flow oxygen therapy application in chronic obstructive pulmonary disease patients with acute hypercapnic respiratory failure: a multicenter study. Crit Care Explor. 2021;3:33-7.
Mohamed ASA, Yasin Mohamed A. Efficacy of high flow nasal cannula oxygenation in acute respiratory failure patients and comparing with noninvasive positive pressure ventilation. Egypt J Med Res. 2022;3:65-71.
Doshi P, Whittle JS, Bublewicz M, Kearney J, Ashe T, Graham R, et al. High-velocity nasal insufflation in the treatment of respiratory failure: a randomized clinical trial. Ann Emerg Med. 2018;72:73-83.
Chandel A, Patolia S, Brown AW, Collins AC, Sahjwani D, Khangoora V, et al. High-flow nasal cannula therapy in COVID-19: using the ROX index to predict success. Respir Care. 2021;66:909-19.
Cortegiani A ,Crimi C, Noto A, Helviz Y ,Giarratano A ,Cregoretti C et al. Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate . Critical Care. 2019; 23(1):1-6.
Vargas F, Saint-Leger M, Boyer A, Bui NH, Hilbert G. Physiologic effects of high-flow nasal cannula oxygen in critical care subjects. Respir Care. 2015;60:1369-76.
Peng Y, Dai B, Zhao HW, Wang W, Kang J, Hou HJ, et al. Comparison between high-flow nasal cannula and noninvasive ventilation in COVID-19 patients: a systematic review and meta-analysis. Ther Adv Respir Dis. 2022;16:175-80.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
